Federal Grand Jury Probes Merck’s Handling of Vioxx
Merck & Co. is the subject of a federal grand-jury probe into its sales and marketing practices for Vioxx, the painkiller it pulled from the market in 2004, according to a person familiar with the matter.
The health-care-fraud unit of the U.S. Attorney’s Office for the District of Massachusetts is investigating whether Merck promoted Vioxx to health-care professionals for uses other than those approved by government regulators, a practice known as off-label marketing, this person said.
Learn More: Wall Street Journal
Popularity: 46% [?]

Pingback by Health Professionals on The Finance World For News and Information Around The World On Finance » Blog Archive » Federal Grand Jury Probes Merck’s Handling of Vioxx on 6 February 2008:
[...] Federal Grand Jury Probes Merck’s Handling of Vioxx Office for the District of Massachusetts is investigating whether Merck promoted Vioxx to health-care professionals for uses other than those… [...]